The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Double-Blind, Randomized, Controlled, Pilot Study Comparing Classic Ayurvedic Medicine, Methotrexate, and Their Combination in Rheumatoid Arthritis
Abstract
OBJECTIVE: To compare classic Ayurveda, methotrexate (MTX), and their combination in a double-blind, randomized, double-dummy, pilot trial in rheumatoid arthritis (RA) for 36 weeks. METHODS: Forty-three seropositive RA patients by American College of Rheumatology (ACR) criteria with disease duration of less than 7 years were assigned to the following treatment groups: MTX plus Ayurvedic placebo (n = 14), Ayurveda plus MTX placebo (n = 12), or Ayurveda plus MTX (n = 17). Outcomes included the Disease Activity Score (DAS28-CRP), ACR20/50/70, and Health Assessment Questionnaire--Disability Index. All measures were obtained every 12 weeks for 36 weeks. Analyses included descriptive statistics, analysis of variance, χ², or Student t test. The unique features of this study included the development of placebos for each Ayurvedic pharmacological dosage form and individualization of Ayurvedic therapy. RESULTS: All groups were comparable at baseline in demographics and disease characteristics. There were no statistically significant differences among the 3 groups on the efficacy measures. ACR20 results were MTX 86%, Ayurveda 100%, and combination 82%, and DAS28-CRP response were MTX -2.4, Ayurveda -1.7, and combination -2.4. Differences in adverse events among groups were also not statistically significant, although the MTX groups experienced more adverse event (MTX 174, Ayurveda 112, combination 176). No deaths occurred. CONCLUSIONS: In this first-ever, double-blind, randomized, placebo-controlled pilot study comparing Ayurveda, MTX, and their combination, all 3 treatments were approximately equivalent in efficacy, within the limits of a pilot study. Adverse events were numerically fewer in the Ayurveda-only group. This study demonstrates that double-blind, placebo-controlled, randomized studies are possible when testing individualized classic Ayurvedic versus allopathic treatment in ways acceptable to western standards and to Ayurvedic physicians. It also justifies the need for larger studies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This was a substantive reformulation which became the basis of the controversy between 'pure' śuddha and integrated Ayurveda in the years to come and gained momentum in the post-colonial period, forever influencing the teaching, research, and practice of Ayurveda.$^{1}$^{3}”
From Contemporary Conversations between Ayurveda and Biomedicine (2014) · cites this paper as [13]
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
American college of rheumatology preliminary definition of improvement in rheumatoid arthritis
Felson, D. T., Anderson, J. J., Boers, M., Bombardier, C., Fürst, D. E., Goldsmith, C. H., Katz, L. M. G., Lightfoot, R. W., Paulus, H. E., Strand, V., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380602 · Cited by 2,825
Emery, P., Fleischmann, R., Filipowicz‐Sosnowska, A., Schechtman, J., Szczepanski, L., Kavanaugh, A., Racewicz, A. J., van Vollenhoven, R., Li, N. F., Agarwal, S. K., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21778 · Cited by 1,061
PRIMER ON THE RHEUMATIC DISEASES
Committee of the American Rheumatism Association (1959) · JAMA · doi:10.1001/jama.1959.73010270003011 · Cited by 806
Schiff, M. H., Keiserman, M., Codding, C., Songcharoen, S., Berman, A., Nayiager, S., Saldate, C., Li, T., Aranda, R., Becker, J.-C., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.080002 · Cited by 540
Kay, J., Matteson, E. L., Dasgupta, B., Nash, P., Durez, P., Hall, S., Hsia, E. C., Han, J., Wagner, C., Xu, Z., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23383 · Cited by 295
van Gestel, A. M., Anderson, J. J., van Riel, P. L. C. M., Boers, M., HAAGSMA, C. J., Rich, B., Wells, G. A., Lange, M., & Felson, D. T. (1999) · PubMed · Cited by 250
HAAGSMA, C. J., van Riel, P. L., de Jong, A. J., & van de Putte, L. B. (1997) · Rheumatology · doi:10.1093/rheumatology/36.10.1082 · Cited by 231
Chopra, A., Lavin, P. T., Patwardhan, B., & Chitre, D. (2000) · PubMed · Cited by 87
Ayurveda: a historical perspective and principles of the traditional healthcare system in India.
Mishra, L. C., Singh, B., & Dagenais, S. (2001) · PubMed · Cited by 79
Research works printed but not linked: 4
- George, 1985, Ray of hope., WHO Bulletin, 112-, 116
- Venkatraman, 2002, Ayurveda: general principles and treatment of rheumatoid arthritis., Altern Med Alert, 5, 144
- Van Gestel, 1999, ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials., J Rheumatol, 26, 705
- Sander, 1998, Is H15 (extract of Boswellia serrata, "incense") an efficient supplementation to established drug therapy in RA? Results of a double blind pilot trial., J Rheumatol, 57, 11
Cited by
Ayurvedic research and methodology: Present status and future strategies
Semwal, D. K., Chauhan, A., Mishra, S. P., & Semwal, R. B. (2015) · AYU (An International Quarterly Journal of Research in Ayurveda) · doi:10.4103/0974-8520.190699 · Cited by 179
Witt, C. M., Michalsen, A., Roll, S., Morandi, A., Gupta, S., Rosenberg, M., Kronpaß, L., Stapelfeldt, E., Hissar, S. S., Müller, M., et al. (2013) · Trials · doi:10.1186/1745-6215-14-149 · Cited by 77
Keßler, C. S., Dhiman, K. S., Kumar, A. B., Ostermann, T., Gupta, S., Morandi, A., Mittwede, M., Stapelfeldt, E., Spoo, M., Icke, K., et al. (2018) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2018.01.022 · Cited by 67
Ayurveda research: Emerging trends and mapping to sustainable development goals
Nedungadi, P., Salethoor, S. N., Puthiyedath, R., Nair, V. K., Keßler, C. S., & Raghu Raman, R. (2023) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2023.100809 · Cited by 62
Approaches in fostering quality parameters for medicinal botanicals in the Indian context
Birdi, T., Gupta, P., & Daswani, P. G. (2014) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.135946 · Cited by 59
Metadata
- Authors
- Furst, D. E., Venkatraman, M. M., McGann, M., Manohar, P. R., Booth-LaForce, C., Sarin, R., Sekar, P. G., Raveendran, K. G., Mahapatra, A., Gopinath, J., & Kumar, P. R. K.
- Affiliations
- University of Washington (US)
- University of California, Los Angeles (US)
- King Edward Memorial Hospital and Seth G.S. Medical College (IN)
- Corresponding author
- McGann, Mary
- Sekar, P.G.
- ORCID
- Kumar, P.R. Krishna
- Venue
- JCR: Journal of Clinical Rheumatology
- Published
- 2011-06
- Volume
- 17
- Issue
- 4
- Pages
- 185-192
- ISSN
- 1076-1608 (ISSN-L)
- OpenAlex
- W1970808527
- Cited by
- 79
- References
- 18
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 9 · 2023: 7 · 2022: 6 · 2021: 3 · 2020: 6 · 2019: 4 · 2018: 4 · 2017: 4 · 2016: 4 · 2015: 6 · 2014: 6 · 2013: 10 · 2012: 2
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JCR Journal of Clinical Rheumatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r21at001969-03)
- National Center for Complementary and Integrative Health (1 R21 AT-01969)
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Keywords
- rheumatoid arthritis, Ayurveda, methotrexate, combination therapy, disease activity, ACR20 response, DAS28-CRP, HAQ-DI, adverse events
- MeSH terms
- Adult, Arthritis, Rheumatoid, Dose-Response Relationship, Drug, Double-Blind Method, Female, Humans, Male, Medicine, Ayurvedic, Methotrexate, Middle Aged, Pilot Projects, Severity of Illness Index, Treatment Outcome, Outcome Assessment, Health Care, Antirheumatic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
